Stocks-BIIB-Biogen Inc

BIIB Biogen Inc

239.12 5.25 (2.24%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: Biogen Inc's revenues decreased by 7.36% and amounted to 10.17B. Net income increased by 71.58% to 2.96B. Net assets increased by 22.16% to 13.39B and EPS increased from 10.40 to 20.87.
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
Net Profit Margin
Operating Margin
Return On Investment